The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Protein Drugs-Global Market Insights and Sales Trends 2025

Protein Drugs-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1839675

No of Pages : 101

Ask Your Query

Synopsis

A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.

The global Protein Drugs market size is expected to reach US$ 439710 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029. The market is mainly driven by the significant applications of Protein Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Protein Drugs market. Antibody Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Peptide Hormones segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Protein Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Protein Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Protein Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Protein Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Protein Drugs covered in this report include Eli Lilly, Abbott Laboratories, UCB Group, Schering-Plough Corporation, Genentech, Johnson＆Johnson, Bristol-Myers Squibb, Novo Nordisk and Biogen Idec, etc.

The global Protein Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Eli Lilly
  • Abbott Laboratories
  • UCB Group
  • Schering-Plough Corporation
  • Genentech
  • Johnson＆Johnson
  • Bristol-Myers Squibb
  • Novo Nordisk
  • Biogen Idec
  • Dendreon Corporation
  • Amgen Inc.

Global Protein Drugs market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Protein Drugs market, Segment by Type:

  • Antibody Drugs
  • Peptide Hormones
  • Blood Products
  • Enzymes

Global Protein Drugs market, by Application:

  • Hospitals
  • Clinics
  • Other

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Protein Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Protein Drugs
1.1 Protein Drugs Market Overview
1.1.1 Protein Drugs Product Scope
1.1.2 Protein Drugs Market Status and Outlook
1.2 Global Protein Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Protein Drugs Market Size by Region (2018-2029)
1.4 Global Protein Drugs Historic Market Size by Region (2018-2023)
1.5 Global Protein Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Protein Drugs Market Size (2018-2029)
1.6.1 North America Protein Drugs Market Size (2018-2029)
1.6.2 Europe Protein Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Protein Drugs Market Size (2018-2029)
1.6.4 Latin America Protein Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Protein Drugs Market Size (2018-2029)
2 Protein Drugs Market by Type
2.1 Introduction
2.1.1 Antibody Drugs
2.1.2 Peptide Hormones
2.1.3 Blood Products
2.1.4 Enzymes
2.2 Global Protein Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Protein Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Protein Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Protein Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Protein Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Protein Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Protein Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Protein Drugs Revenue Breakdown by Type (2018-2029)
3 Protein Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Protein Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Protein Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Protein Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Protein Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Protein Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Protein Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Protein Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Protein Drugs Revenue Breakdown by Application (2018-2029)
4 Protein Drugs Competition Analysis by Players
4.1 Global Protein Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Protein Drugs as of 2022)
4.3 Date of Key Players Enter into Protein Drugs Market
4.4 Global Top Players Protein Drugs Headquarters and Area Served
4.5 Key Players Protein Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Protein Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Protein Drugs Products, Services and Solutions
5.1.4 Eli Lilly Protein Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Protein Drugs Products, Services and Solutions
5.2.4 Abbott Laboratories Protein Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 UCB Group
5.3.1 UCB Group Profile
5.3.2 UCB Group Main Business
5.3.3 UCB Group Protein Drugs Products, Services and Solutions
5.3.4 UCB Group Protein Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Schering-Plough Corporation Recent Developments
5.4 Schering-Plough Corporation
5.4.1 Schering-Plough Corporation Profile
5.4.2 Schering-Plough Corporation Main Business
5.4.3 Schering-Plough Corporation Protein Drugs Products, Services and Solutions
5.4.4 Schering-Plough Corporation Protein Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Schering-Plough Corporation Recent Developments
5.5 Genentech
5.5.1 Genentech Profile
5.5.2 Genentech Main Business
5.5.3 Genentech Protein Drugs Products, Services and Solutions
5.5.4 Genentech Protein Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Genentech Recent Developments
5.6 Johnson＆Johnson
5.6.1 Johnson＆Johnson Profile
5.6.2 Johnson＆Johnson Main Business
5.6.3 Johnson＆Johnson Protein Drugs Products, Services and Solutions
5.6.4 Johnson＆Johnson Protein Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson＆Johnson Recent Developments
5.7 Bristol-Myers Squibb
5.7.1 Bristol-Myers Squibb Profile
5.7.2 Bristol-Myers Squibb Main Business
5.7.3 Bristol-Myers Squibb Protein Drugs Products, Services and Solutions
5.7.4 Bristol-Myers Squibb Protein Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol-Myers Squibb Recent Developments
5.8 Novo Nordisk
5.8.1 Novo Nordisk Profile
5.8.2 Novo Nordisk Main Business
5.8.3 Novo Nordisk Protein Drugs Products, Services and Solutions
5.8.4 Novo Nordisk Protein Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Novo Nordisk Recent Developments
5.9 Biogen Idec
5.9.1 Biogen Idec Profile
5.9.2 Biogen Idec Main Business
5.9.3 Biogen Idec Protein Drugs Products, Services and Solutions
5.9.4 Biogen Idec Protein Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Biogen Idec Recent Developments
5.10 Dendreon Corporation
5.10.1 Dendreon Corporation Profile
5.10.2 Dendreon Corporation Main Business
5.10.3 Dendreon Corporation Protein Drugs Products, Services and Solutions
5.10.4 Dendreon Corporation Protein Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Dendreon Corporation Recent Developments
5.11 Amgen Inc.
5.11.1 Amgen Inc. Profile
5.11.2 Amgen Inc. Main Business
5.11.3 Amgen Inc. Protein Drugs Products, Services and Solutions
5.11.4 Amgen Inc. Protein Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Amgen Inc. Recent Developments
6 North America
6.1 North America Protein Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Protein Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Protein Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Protein Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Protein Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Protein Drugs Market Dynamics
11.1 Protein Drugs Industry Trends
11.2 Protein Drugs Market Drivers
11.3 Protein Drugs Market Challenges
11.4 Protein Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock